Harrington Discovery Institute Announces New Fund to Advance Breakthrough Discoveries into Novel Treatments
The Advent-Harrington Impact Fund contributes to $215 million close of Advent Life Sciences’ funds focused on areas of high unmet medical need
Newswise CLEVELAND The transatlantic, not-for-profit medical accelerator, Harrington Discovery Institute (HDI) at University Hospitals, has collaborated with leading venture investor, Advent Life Sciences (‘Advent’) in the launch of the Advent-Harrington Impact Fund.
Advent’s new impact fund, structured alongside Advent Life Sciences Fund III, brings a total of $215 million to advance breakthrough discoveries into novel treatments for the benefit of patients and society.
Advent-Harrington Impact Fund, a market rate investment fund, breaks new ground through a partnership with a novel philanthropic vehicle at Morgan Stanley Wealth Management (MS GIFT Cures powered by HDI). Profits from Advent-Harrington Impact Fund are sha
Harrington Discovery Institute at University Hospitals joins with Advent Life Sciences to launch fund
crainscleveland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crainscleveland.com Daily Mail and Mail on Sunday newspapers.
Advent Life Sciences Announces Close of Two New Funds Totalling $215 million to Translate Early-Stage Research into Impactful Medicines for Patients
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.